Phase 2 Ampullary Adenocarcinoma Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels

Esophageal AdenocarcinomaGastric AdenocarcinomaPancreas Adenocarcinoma+6 more

Yale University54 enrolled1 locationNCT07282912

Recruiting

Phase 1Phase 2

Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula

Adenocarcinoma of the PancreasAdenocarcinoma of the DuodenumAmpullary Adenocarcinoma

University Hospital, Lille36 enrolled1 locationNCT05116072